{{Rsnum
|rsid=12935229
|Gene=ADAMTS18
|Chromosome=16
|position=77294998
|Orientation=plus
|GMAF=0.1258
|Gene_s=ADAMTS18
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 74.3 | 21.2 | 4.4
| HCB | 61.3 | 35.0 | 3.6
| JPT | 72.6 | 26.5 | 0.9
| YRI | 100.0 | 0.0 | 0.0
| ASW | 94.7 | 5.3 | 0.0
| CHB | 61.3 | 35.0 | 3.6
| CHD | 61.5 | 36.7 | 1.8
| GIH | 85.1 | 13.9 | 1.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 60.3 | 32.8 | 6.9
| MKK | 98.1 | 1.9 | 0.0
| TSI | 69.6 | 28.4 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=A
  |Pval=4E-6
  |OR=1.50
  |ORtxt=[1.214-1.84]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}